Simultaneous presentation of pulmonary embolism and pericardial effusion as complications of cancer: a case report

[1] Quint LE. Thoracic complications and emergencies in oncologic patients. Cancer Imaging 2009;9 Spec No A(Special issue A):S75–82. Search in Google Scholar

[2] Haen P, Mege D, Crescence L, Dignat-George F, Dubois C, Panicot-Dubois L. Thrombosis risk associated with head and neck cancer: a review. Int J Mol Sci 2019; 20(11):2838. Search in Google Scholar

[3] Bĕlohlávek J, Dytrych V, Linhart A. Pulmonary embolism, part I: epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. Exp Clin Cardiol 2013; 18(2):129–38. Search in Google Scholar

[4] Wickham N, Gallus AS, Walters BNJ, Wilson A, NHMRC VTE Prevention Guideline Adaptation Committee. Prevention of venous thromboembolism in patients admitted to Australian hospitals: summary of National Health and Medical Research Council clinical practice guideline. Intern Med J 2012; 42(6):698–708. Search in Google Scholar

[5] Lestuzzi C. Neoplastic pericardial disease: old and current strategies for diagnosis and management. World J Cardiol 2010; 2(9):270–9. Search in Google Scholar

[6] Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J, et al. 2015 ESC guidelines for the diagnosis and management of pericardial diseases. Eur Heart J 2015; 36(42):2921–64. Search in Google Scholar

[7] Pabba K, Rojas-Hernandez CM. Concurrent presentation of a hemorrhagic pericardial effusion and venous thromboembolism in malignancy: a systematic review of case studies. J Thromb Thrombolysis 2019; 48(3):454–8. Search in Google Scholar

[8] Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, et al. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Respir J 2019; 41(4):543–603. Search in Google Scholar

[9] Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest 2016; 149(2):315–52. Search in Google Scholar

[10] Mandalà M, Falanga A, Roila F, ESMO guidelinesWorking Group. Management of venous thromboembolism (VTE) in cancer patients: ESMO clinical practice guidelines. Ann Oncol Off J Eur Soc Med Oncol 2011; 22 Suppl 6:vi85–92. Search in Google Scholar

[11] Key NS, Khorana AA, Kuderer NM, Bohlke K, Lee AYY, Arcelus JI, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol 2020; 38(5):496–520. Search in Google Scholar

[12] Ferris RL, Blumenschein G, Fayette J, Guigay J, Colevas AD, Licitra L, et al. Nivolumab for recurrent squamous-cell carcinoma of the head and neck. N Engl J Med 2016; 375(19):1856–67. Search in Google Scholar

[13] Jairath UC, Benotti JR, Spodick DH. Cardiac tamponade masking pulmonary embolism. Clin Cardiol 2001; 24(6):485–6. Search in Google Scholar

[14] Akhbour S, Khennine BA, Oukerraj L, Zarzur J, Cherti M. Pericardial tamponade and coexisting pulmonary embolism as first manifestation of non-advanced lung adenocarcinoma. Pan Afr Med J 2014; 18:15. Search in Google Scholar

[15] Thomas C, Lane K, Cecconi M. Pulmonary embolism with haemorrhagic pericardial effusion and tamponade: a clinical dilemma. BMJ Case Rep 2014; 2014:bcr2013202285. Search in Google Scholar

[16] Kandasamy S, Tadi MEF, Rudrapogu JS, Biju G, Boddikura C, Naralasetty AK. Pericardial tamponade masking associated pulmonary thrombo embolism in a case of adeno carcinoma of lung. Int J Res Med Sci 2017; 3(8):2126–8. Search in Google Scholar

[17] Cagnina RE, Gay EB. An elderly man with dyspnea and chest pain. Chest 2016; 149(1):e7–9. Search in Google Scholar

[18] Huang K, Huang SY, Cheng SY, Tsai MT, Hung M. Massive pulmonary embolism concomitant with cardiac tamponade as initial presentation of lung adenocarcinoma: a diagnostic and therapeutic dilemma. J Acute Med 2019; 9(1):24–8. Search in Google Scholar

[19] Pazooki B, Sherafati A. Management of pulmonary embolism and pericardial effusion. Case Rep Clin Pract 2019; 4(2):48–51. Search in Google Scholar

[20] Pathak V, Manivel V. Defying Occam’s razor: a case of pulmonary embolism masked by cardiac tamponade. J Emerg Med 2022; 62(2):e23–7. Search in Google Scholar

[21] Kosugi M, Ono T, Yamaguchi H, Sato N, Dan K, Tanaka K, et al. Successful treatment of primary cardiac lymphoma and pulmonary tumor embolism with chemotherapy. Int J Cardiol 2006; 111(1):172–3. Search in Google Scholar

[22] Bohlmann MK, Eckstein FS, Stauffer E, Allemann Y, Carrel TP. Isolated amelanotic malignant melanoma of the heart. Br J Dermatol 2002; 146(5):912–5. Search in Google Scholar

[23] Sardar MR, Kuntz C, Patel T, Saeed W, Gnall E, Imaizumi S, et al. Primary pericardial mesothelioma unique case and literature review. Tex Heart Inst J 2012; 39(2):261–4. Search in Google Scholar